2026-10-05 · This surge has been running 5 days. This page updates daily until traffic returns to normal.
Pentobarbital is drawing 187x more Wikipedia traffic than normal
Pentobarbital drew 117,542 views on 2026-10-01, 187x more than the usual 627 a day over the previous 60 days.
Pentobarbital
Short-acting barbiturate
View as table
| Date | Views |
|---|---|
| 2026-10-05 | 10,985 |
| 2026-10-04 | 16,670 |
| 2026-10-03 | 29,541 |
| 2026-10-02 | 57,727 |
| 2026-10-01 | 117,542 |
| 2026-09-30 | 2,346 |
| 2026-09-29 | 1,333 |
| 2026-09-28 | 949 |
| 2026-09-27 | 741 |
| 2026-09-26 | 635 |
| 2026-09-25 | 729 |
| 2026-09-24 | 999 |
| 2026-09-23 | 754 |
| 2026-09-22 | 682 |
| 2026-09-21 | 618 |
| 2026-09-20 | 564 |
| 2026-09-19 | 662 |
| 2026-09-18 | 1,190 |
| 2026-09-17 | 942 |
| 2026-09-16 | 760 |
| 2026-09-15 | 604 |
| 2026-09-14 | 550 |
| 2026-09-13 | 600 |
| 2026-09-12 | 784 |
| 2026-09-11 | 677 |
| 2026-09-10 | 634 |
| 2026-09-09 | 632 |
| 2026-09-08 | 716 |
| 2026-09-07 | 715 |
| 2026-09-06 | 663 |
| 2026-09-05 | 579 |
| 2026-09-04 | 543 |
| 2026-09-03 | 580 |
| 2026-09-02 | 634 |
| 2026-09-01 | 558 |
| 2026-08-31 | 591 |
| 2026-08-30 | 584 |
| 2026-08-29 | 598 |
| 2026-08-28 | 601 |
| 2026-08-27 | 633 |
| 2026-08-26 | 567 |
| 2026-08-25 | 566 |
| 2026-08-24 | 616 |
| 2026-08-23 | 645 |
| 2026-08-22 | 556 |
What this article is
Pentobarbital is a short-acting barbiturate typically used as a sedative, a preanesthetic, and to control convulsions in emergencies. It can also be used for short-term treatment of insomnia but has been largely replaced by the benzodiazepine family of drugs.
Summary text from the Wikipedia article "Pentobarbital", available under CC BY-SA 4.0. Read the full article.
How this was measured
Views are Wikimedia's own pageview counts for en.wikipedia, filtered to agent=user so automated traffic is excluded. The baseline is the median of the previous 60 days, which is used instead of the mean so that an earlier surge cannot flatten a later one. The multiple is the day's views divided by that median.